TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/6/21 18:49 | 7/2/21 | ZGNX | Zogenix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sagrolikar Ashish M | CA | O | EVP,CHIE | M.d | 0 | 0.00 | 0 | 4 | 28 | 16 | D | ||||||||||||||
3/17/21 16:02 | 3/15/21 | ZGNX | Zogenix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sagrolikar Ashish M | CA | O | EVP,CHIE | M.d | 0 | 0.00 | 0 | 5 | 55 | 13 | D | ||||||||||||||
7/6/20 16:37 | 7/2/20 | ZGNX | Zogenix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sagrolikar Ashish M | CA | O | EVP,CHIE | M.d | 0 | 0.00 | 0 | 4 | 70 | 9 | D | ||||||||||||||
5/11/20 18:18 | 5/8/20 | ZGNX | Zogenix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sagrolikar Ashish M | CA | O | EVP,CHIE | P | 25 | 25.45 | 0 | 1 | 20 | 6 | D | ||||||||||||||
3/17/20 19:25 | 3/15/20 | ZGNX | Zogenix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sagrolikar Ashish M | CA | O | EVP,CHIE | M.d | 0 | 0.00 | 0 | 2 | 71 | 5 | D | ||||||||||||||
7/5/19 19:11 | 7/2/19 | ZGNX | Zogenix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sagrolikar Ashish M | CA | O | EVP,CHIE | M.d | 0 | 0.00 | 0 | 4 | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |